Projects per year
Personal profile
Biography
Dr Pouya Faridi is the head of the Translational Antigen Discovery Laboratory at the School of Clinical Sciences, Monash University. After completing his pharmacy doctorate and PhD at the Shiraz University of Medical Sciences, Iran, he joined Prof Ruedi Aebersold’s laboratory at Institute for Molecular Systems Biology at the ETH Zurich, Switzerland. In 2016, he moved to Australia and joined Prof Tony Purcell’s lab at Biomedicine Discovery Institute, Monash University. In 2021, he established his own laboratory at the Department of Medicine, Monash University.
Dr Faridi has developed several mass-spectrometry and proteomics technologies to identify and quantify peptides, proteins, and metabolites. He has applied these technologies to identify and validate actionable targets for cancer immunotherapy. Some of the peptides he identified are currently used for cancer vaccination clinical studies. In addition to his research lab, Dr Faridi is the co-director of the Monash Clinical Proteomics Facility.
Dr Faridi’s research excellence is shown by the mid-career fellowship from the Victorian Cancer Agency for the development of precision vaccines for devastating paediatric brain tumours. He has several patents in the antigen discovery field, and his research has been published in prestigious journals, including Cell, Science Immunology, Nature Communications and Cancer Immunology Research. Faridi lab is supported by NHMRC, Cancer Australia, Australian Melanoma Research Foundation and Isabella & Marcus Foundation.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
External positions
Honorary Research Associate, Hudson Institute of Medical Research
12 Aug 2021 → …
Network
-
Dominant classes of tumour specific antigens in Melanoma
Purcell, A., Faridi, P., Shackleton, M., Linette, G. & Behren, A.
1/01/22 → 31/12/24
Project: Research
-
Pioneering novel therapeutic strategies to enhance an anti-tumour immune response in Neuroblastoma
Vittorio, O., Saletta, F., Murray, J., Mayoh, C. & Faridi, P.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/22 → 31/12/24
Project: Research
-
-
The development of precision vaccines for devastating paediatric brain tumours
Faridi, P., Purcell, A., Nazarian, J., Hansford, J. R., Jabado, N., Linette, G., Behren, A. & Cain, J.
19/03/21 → 18/03/25
Project: Research
-
Novel targets for paediatric brain tumour immunotherapy
Purcell, A., Faridi, P., Nazarian, J., Jabado, N. & Hansford, J.
1/01/21 → 31/12/22
Project: Research
-
MhcVizPipe: A Quality Control Software for Rapid Assessment of Small- To Large-Scale Immunopeptidome Datasets
Kovalchik, K. A., Ma, Q., Wessling, L., Saab, F., Duquette, J. D., Kubiniok, P., Hamelin, D. J., Faridi, P., Li, C., Purcell, A. W., Jang, A., Paramithiotis, E., Tognetti, M., Reiter, L., Bruderer, R., Lanoix, J., Bonneil, É., Courcelles, M., Thibault, P., Caron, E. & 1 others, , Jan 2022, In: Molecular & Cellular Proteomics. 21, 1, 15 p., 100178.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Anthem: a user customised tool for fast and accurate prediction of binding between peptides and HLA class I molecules
Mei, S., Li, F., Xiang, D., Ayala, R., Faridi, P., Webb, G. I., Illing, P. T., Rossjohn, J., Akutsu, T., Croft, N. P., Purcell, A. W. & Song, J., Sep 2021, In: Briefings in Bioinformatics. 22, 5, p. 1-16 16 p., bbaa415.Research output: Contribution to journal › Article › Research › peer-review
5 Citations (Scopus) -
IFNγ Modulates the Immunopeptidome of Triple Negative Breast Cancer Cells by Enhancing and Diversifying Antigen Processing and Presentation
Goncalves, G., Mullan, K. A., Duscharla, D., Ayala, R., Croft, N. P., Faridi, P. & Purcell, A. W., 22 Apr 2021, In: Frontiers in Immunology. 12, 13 p., 645770.Research output: Contribution to journal › Article › Research › peer-review
Open Access7 Citations (Scopus) -
Reinspection of a clinical proteomics tumor analysis consortium (Cptac) dataset with cloud computing reveals abundant post-translational modifications and protein sequence variants
Prakash, A., Taylor, L., Varkey, M., Hoxie, N., Mohammed, Y., Goo, Y. A., Peterman, S., Moghekar, A., Yuan, Y., Glaros, T., Steele, J. R., Faridi, P., Parihari, S., Srivastava, S., Otto, J. J., Nyalwidhe, J. O., Semmes, O. J., Moran, M. F., Madugundu, A., Mun, D. G. & 5 others, , 2 Oct 2021, In: Cancers. 13, 20, 15 p., 5034.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Resourcing, annotating, and analysing synthetic peptides of SARS-CoV-2 for immunopeptidomics and other immunological studies
Li, C., Revote, J., Ramarathinam, S. H., Chung, S. Z., Croft, N. P., Scull, K. E., Huang, Z., Ayala, R., Braun, A., Mifsud, N. A., Illing, P. T., Faridi, P. & Purcell, A. W., Sep 2021, In: Proteomics. 21, 17-18, 11 p., e2100036.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus)
Prizes
-
Australasian Proteomics Society Early Career Researcher Award
Faridi, Pouya (Recipient), Feb 2019
Prize: Prize (including medals and awards)
-
Australasian Proteomics Society Early Career Researcher Travel Grant
Faridi, Pouya (Recipient), 2017
Prize: Prize (including medals and awards)
-
Australian Melanoma Research Foundation Early Career Researcher award
Faridi, Pouya (Recipient), 2021
Prize: National/international honour
-
European Molecular Biology Organization (EMBO) Postdoctoral Travel Grant
Faridi, Pouya (Recipient), May 2019
Prize: Prize (including medals and awards)
-
Monash University BDI Awards for Outstanding International Collaboration
Faridi, Pouya (Recipient), 6 Dec 2019
Prize: Prize (including medals and awards)
Activities
- 1 Hosting an academic or industry visitor
-
Saad Khilji
Pouya Faridi (Host)
1 Feb 2020 → 20 Nov 2020Activity: Hosting a visitor types › Hosting an academic or industry visitor